Top 11 CRISPR Stocks to Invest In
The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital...
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Partner Fund Management Christopher Medlock James | 3,876,462 | $6,163,575 | -10% | 0.38% |
2. | Kynam Capital Derrick Tang | 2,406,147 | $3,825,774 | +3% | 0.22% |
3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 2,113,272 | $3,360,102 | +29% | 0.01% |
4. | Two Sigma Advisors John Overdeck And David Siegel | 1,470,700 | $2,338,413 | +40% | 0% |
5. | Point72 Asset Management Steve Cohen | 1,024,989 | $1,629,732 | -52% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.02 | 20,000 | Officer, Director | 3,369,395 | 2025-03-14 | Filing | |
$1.42 | 17,360 | Officer | 17,360 | 2025-01-29 | Filing | |
$4.11 | 6,818 | Officer | 109,082 | 2022-01-11 | Filing | |
$2.69 | 569 | Officer | 102,264 | 2022-01-11 | Filing | |
$2.69 | 1,136 | Officer | 101,695 | 2021-12-20 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.35 | 3,564 | Officer | 443,502 | 2025-02-21 | Filing | |
$1.35 | 3,564 | Officer | 66,936 | 2025-02-21 | Filing | |
$1.35 | 3,564 | Officer | 431,556 | 2025-02-21 | Filing | |
$6.31 | 5,627 | Officer | 59,373 | 2023-01-19 | Filing | |
$10.80 | 10,000 | Officer | 110,366 | 2022-10-06 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 6,346,438 | $5,794,934 | 0% | |
2. | 4,522,032 | $4,128,615 | 0% | |
3. | 822,840 | $751,335 | 0% | |
4. | 727,222 | $664,026 | 0% | |
5. | 468,240 | $427,550 | 0.18% |